Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
284 studies found for:    "Tetanus"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
Condition: Tetanus
Interventions: Drug: Tetanus Immune Globulin (Human);   Biological: Diphtheria-Tetanus Toxoids Adsorbed
2 Completed The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td
Condition: Tetanus
Intervention:
3 Completed Pneumonia in Tetanus Study
Condition: Tetanus
Interventions: Other: semi-recumbent;   Other: supine
4 Completed
Has Results
Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
Conditions: Diphtheria;   Tetanus
Intervention: Biological: Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine
5 Completed Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain
Conditions: Tetanus;   Tetanus Vaccine
Intervention: Biological: Tetanus toxoid vaccine
6 Completed
Has Results
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis
7 Unknown  An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
Conditions: Tetanus;   Diphtheria;   Pertussis
Interventions: Biological: Td5ap;   Biological: Td1aP
8 Active, not recruiting Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
Conditions: Tetanus;   Diphtheria;   Whooping Cough
Interventions: Biological: Biological: GC3111 vaccine;   Biological: Biological: Boostrix® vaccine
9 Completed Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine
Condition: Diphteria, Tetanus and Pertussis
Interventions: Biological: GSK Biologicals' reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine;   Biological: GSK Biologicals' reduced-antigen-content acellular pertussis vaccine;   Biological: Tedivax-Adult™/ Td-Rix™
10 Active, not recruiting Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
Conditions: Tetanus;   Diphtheria;   Pertussis;   Whooping Cough
Interventions: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3;   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4;   Biological: Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed;   Biological: Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
11 Completed Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults
Condition: Healthy
Interventions: Biological: REPEVAX;   Biological: Monovalent Tetanus vaccine
12 Completed
Has Results
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
Conditions: Pertussis;   Whooping Cough;   Tetanus;   Lockjaw;   Diphtheria
Interventions: Biological: Acellular pertussis vaccine;   Biological: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed);   Biological: Licensed TdaP booster vaccine;   Biological: Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany);   Other: Saline solution
13 Completed Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
Conditions: Diphtheria;   Tetanus;   Pertussis;   Polio
Intervention: Drug: Boostrix polio
14 Completed Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients
Condition: Renal Dialysis
Interventions: Drug: Levamisole;   Drug: Placebo
15 Completed Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization
Condition: Healthy
Intervention:
16 Completed Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Concomitant administration;   Biological: Separate administration
17 Completed Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
Conditions: Diphtheria;   Tetanus;   Poliomyelitis;   Pertussis
Intervention: Biological: Diphtheria, tetanus, polio and pertussis vaccination
18 Recruiting Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: DTaP-IPV combination vaccine;   Biological: DTaP vaccine and IPV vaccine
19 Completed REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-Old Children
Conditions: Diphtheria;   Tetanus;   Poliomyelitis
Interventions: Biological: REVAXIS®;   Biological: DT-Polio®
20 Completed Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children
Conditions: Diphtheria,;   Tetanus and Pertussis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.